Skip to content

Syphilis and HIV Point of Care Testing (POCT) in Saskatchewan

HIV Infections | Syphilis

The goal of this clinical trial is to learn about Syphilis and HIV point of care testing among inner city, remote, rural and hard to reach populations in Saskatchewan. The main question\[s\] it aims to answer are:

1. To evaluate the field diagnostic test performance (e.g. sensitivity, specificity, predictive values) of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT, HIV POCT and dual syphilis and HIV POCT.
2. To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically:

1. Time to diagnosis
2. Time to treatment
3. Number of contacts exposed to untreated infections
4. For HIV diagnoses, time to connection to clinical provider for ongoing management of HIV
3. To evaluate the acceptability and feasibility of POCT among different populations for syphilis and HIV among at risk and/or hard to reach populations, specifically:

1. Health care provider experiences of feasibility and acceptability of the POCT used in this pilot
2. Client acceptability and experiences with POCT in this pilot
3. Client preferences for test offered (syphilis only, HIV only, or dual test of HIV and syphilis 4. To evaluate the acceptability and feasibility of syphilis alone, HIV alone or combined syphilis/HIV POCT among at-risk and/or hard to reach populations.

Participants will be assessed for risk factors that may increase risk of infectious disease such as substance use and sexual habits. They will then be offered a choice of 1 of 3 POCT(Syphilis alone, HIV alone or a dual HIV/Syphilis test). Serology will be obtained for sexually transmitted and blood born infections (STBBI's) and then the point of care test (POCT) will be completed. Following the testing the participant will complete a short survey on their experience.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    16 and up

Participation Criteria

Inclusion Criteria:

* 1650 consecutive individuals
* \> 16 years accessing STBBI testing at specific locations and able to provide informed consent. PLWH and persons who are syphilis positive may also eligible to participate.

Exclusion Criteria:

° Less than 16 years, unable to provide signed informed consent (e.g., intoxicated)

Study Location

Queen City Wellness Pharmacy
Queen City Wellness Pharmacy
Regina, Saskatchewan
Canada

Contact Study Team

Primary Contact

Sara Kozusko

[email protected]
(306) 522-2266
Wellness Wheel Medical Clinic
Wellness Wheel Medical Clinic
Regina, Saskatchewan
Canada

Contact Study Team

Backup Contact

Vicky Schultz, RN

[email protected]
1-306-520-3889
Primary Contact

Susanne Nicolay, RN

[email protected]
1-306-520-2846
Study Sponsored By
Wellness Wheel Medical Clinic
Participants Required
More Information
Study ID: NCT05863117